Geoffrey Michael Glass - Net Worth and Insider Trading
Geoffrey Michael Glass Net Worth
The estimated net worth of Geoffrey Michael Glass is at least $726,642 dollars as of 2024-12-01. Geoffrey Michael Glass is the Director of Avadel Pharmaceuticals PLC and owns about 65,700 shares of Avadel Pharmaceuticals PLC (AVDL) stock worth over $726,642. Details can be seen in Geoffrey Michael Glass's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Geoffrey Michael Glass has not made any transactions after 2023-08-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Geoffrey Michael Glass
Geoffrey Michael Glass Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Geoffrey Michael Glass owns 1 companies in total, including Avadel Pharmaceuticals PLC (AVDL) .
Click here to see the complete history of Geoffrey Michael Glass’s form 4 insider trades.
Insider Ownership Summary of Geoffrey Michael Glass
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
AVDL | Avadel Pharmaceuticals PLC | 2023-08-10 | director |
Geoffrey Michael Glass Latest Holdings Summary
Geoffrey Michael Glass currently owns a total of 1 stock. Geoffrey Michael Glass owns 65,700 shares of Avadel Pharmaceuticals PLC (AVDL) as of August 10, 2023, with a value of $726,642.
Latest Holdings of Geoffrey Michael Glass
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
AVDL | Avadel Pharmaceuticals PLC | 2023-08-10 | 65,700 | 11.06 | 726,642 |
Holding Weightings of Geoffrey Michael Glass
Geoffrey Michael Glass Form 4 Trading Tracker
According to the SEC Form 4 filings, Geoffrey Michael Glass has made a total of 5 transactions in Avadel Pharmaceuticals PLC (AVDL) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Avadel Pharmaceuticals PLC is the acquisition of 14,000 shares on August 10, 2023, which cost Geoffrey Michael Glass around $187,600.
Insider Trading History of Geoffrey Michael Glass
- 1
Geoffrey Michael Glass Trading Performance
GuruFocus tracks the stock performance after each of Geoffrey Michael Glass's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Geoffrey Michael Glass is 63.67%. GuruFocus also compares Geoffrey Michael Glass's trading performance to market benchmark return within the same time period. The performance of stocks bought by Geoffrey Michael Glass within 3 months outperforms 4 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Geoffrey Michael Glass's insider trading performs compared to the benchmark.
Performance of Geoffrey Michael Glass
Geoffrey Michael Glass Ownership Network
Geoffrey Michael Glass Owned Company Details
What does Avadel Pharmaceuticals PLC do?
Who are the key executives at Avadel Pharmaceuticals PLC?
Geoffrey Michael Glass is the director of Avadel Pharmaceuticals PLC. Other key executives at Avadel Pharmaceuticals PLC include Chief Financial Officer Thomas S Mchugh , director & Chief Executive Officer Greg J Divis , and Chief Commercial Officer Richard J Kim .
Avadel Pharmaceuticals PLC (AVDL) Insider Trades Summary
Over the past 18 months, Geoffrey Michael Glass made 1 insider transaction in Avadel Pharmaceuticals PLC (AVDL) with a net purchase of 14,000. Other recent insider transactions involving Avadel Pharmaceuticals PLC (AVDL) include a net sale of 103,975 shares made by Mark Anthony Mccamish , a net purchase of 4,000 shares made by Thomas S Mchugh , and a net purchase of 10,000 shares made by Greg J Divis .
In summary, during the past 3 months, insiders sold 0 shares of Avadel Pharmaceuticals PLC (AVDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 103,975 shares of Avadel Pharmaceuticals PLC (AVDL) were sold and 28,000 shares were bought by its insiders, resulting in a net sale of 75,975 shares.
Avadel Pharmaceuticals PLC (AVDL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avadel Pharmaceuticals PLC Insider Transactions
Geoffrey Michael Glass Mailing Address
Above is the net worth, insider trading, and ownership report for Geoffrey Michael Glass. You might contact Geoffrey Michael Glass via mailing address: 4721 Emperor Blvd, Suite 200, Durham Nc 27703.